Position Statements & Comments
2009
- Arthritis Foundation Comment on FDA Requirement for Cancer Warnings on TNF Blockers -- Concerned parents reassured that juvenile arthritis outlook remains promising. (08/2009)
- Arthritis Foundation Statement on Medicare Part D Drug Discount Agreement Between the White House, Senate Finance Committee and PHRMA (07/2009)
- Arthritis Foundation Comment on FDA Acetaminophen Recommendations (07/2009)
- Arthritis Foundation Health Care Reform Position Statement (06/2009)
- Arthritis Foundation Statement on Follow-on Biologics (04/2009)
2008
- Arthritis Foundation Comment on Arthroscopic Surgery for Osteoarthritis of the Knee (09/09/08)
- Arthritis Foundation Comment on FDA Announcement on TNF-Blocker Drugs (09/04/08)
- Arthritis Foundation Comment on FDA Ongoing Safety Review of Tumor Necrosis Factor (TNF) Blockers (06/06/08)
2007
- Arthritis Foundation Comment on the Agency for Healthcare Research and Quality Report on Combining Rheumatoid Arthritis Treatments (PDF) (11/21/07)
- FDA Investigates Death in Arthritis Study (7/27/07)
- Chondroitin and Pain Relief (PDF)(4/16/07)
- Arthritis Foundation Chief Public Health Officer Testifies at FDA Hearing on Arcoxia (PDF) (4/11/07)
- Comment on NSAIDs, Arthritis and Cardiovascular Health (PDF) (3/15/07)
2006
- Comment on FDA Proposed Labeling Changes to Over-the-Counter Pain Relievers (PDF) (12/20/06)
- Comment on Acetaminophen and Risk of Liver Damage (Word document) (7/5/06)
- Comment on Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies (PDF) (5/17/06)
- Arthritis Foundation Statement on Rituximab for Rheumatoid Arthritis (PDF) (3/1/06)
- Arthritis Foundation Statement on the Glucosamine/Chondroitin Arthritis Intervention Trial (PDF) (2/23/06)
Questions? Email Us. (Media representatives only, please.)
All others may contact help@arthritis.org.
